Những phát hiện nội soi thanh quản đặc trưng ở bệnh nhân Parkinson sau khi được kích thích não sâu nhân dưới đồi và mối liên hệ của nó với rối loạn giọng nói

Burghaus L, Hilker R, Thiel A, Galldiks N, Lehnhardt FG, Zaro-Weber O et al (2006) Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease. J Neural Transm 113:625–631 Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Res 12:246–269 Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908 Dromey C, Bjarnason S (2011) A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson’s disease. Parkinsons Dis 2011:796205 Dromey C, Kumar R, Lang AE, Lozano AM (2000) An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord 15:1132–1138 Fytagoridis A, Åström M, Wårdell K, Blomstedt P (2013) Stimulation-induced side effects in the posterior subthalamic area: distribution, characteristics and visualization. Clin Neurol Neurosurg 115:65–71 Gallena S, Smith PJ, Zeffiro T, Ludlow CL (2001) Effects of levodopa on laryngeal and offset in Parkinson disease. J Speech Lang Hear Res 44:1284–1299 Gamboa J, Jimnez-jimnez J, Nieto A, Montojo J, Molina A, Cobeta I (1997) Acoustic voice analysis in patients with Parkinson’s disease treated with dopaminergic drugs. J Voice 11:314–320 Goberman AM, Blomgren M (2008) Fundamental Frequency change during offset and onset of voicing in individuals with Parkinson disease. J Voice 22:178–191 Hanson DG, Gerratt BR, Ward PH (1984) Cinegraphic observations of laryngeal function in Parkinson’s disease. Laryngoscope 94:348–353 Hirano M (1981) Clinical examination of voice. Springer-Verlag, New York Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184 Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS (1997) The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70 Karlsson F, Blomstedt P, Olofsson K, Linder J, Nordh E, van Doorn J (2012) Control of phonatory onset and offset in Parkinson patients following deep brain stimulation of the subthalamic nucleus and caudal zona incerta. Park Relat Disord 18:824–827 Klostermann F, Ehlen F, Vesper J, Nubel K, Gross M, Marzinzik F et al (2008) Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 79:522–529 Lowell SY, Kelley RT, Awan SN, Colton RH, Chan NH (2012) Spectral- and cepstral-based acoustic features of dysphonic, strained voice quality. Ann Otol Rhinol Laryngol 121:539–548 Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI (2008) Voice abnormalities and their relation with motor dysfunction in Parkinson’s disease. Acta Neurol Scand 117:26–34 Moreau C, Pennel-Ployart O, Pinto S, Plachez A, Annic A, Viallet F et al (2011) Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson’s disease. Mov Disord 26:659–663 Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P (2004) Treatments for dysarthria in Parkinson’s disease. Lancet Neurol 3:547–556 Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid AL et al (2005) Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Mov Disord 20:1507–1515 Plaha P, Ben-Shlomo Y, Patel NK, Gill SS (2006) Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129:1732–1747 Rehncrona S, Johnels B, Widner H, Törnqvist AL, Hariz M, Sydow O (2003) Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 18:163–170 Reich MM, Steigerwald F, Sawalhe AD, Reese R, Gunalan K, Johannes S (2015) Short pulse width widens the therapeutic window of subthalamic neurostimulation. Ann Clin Transl Neurol 2:427–432 Schaltenbrand G, Wahren W (1977) Atlas for stereotaxy of the human brain, 2nd edn. Thieme, Stuttgart Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L et al (2013) Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 368:610–622 Skodda S, Grönheit W, Schlegel U, Südmeyer M, Schnitzler A, Wojtecki L (2014) Effect of subthalamic stimulation on voice and speech in Parkinson’s disease: for the better or worse? Front Neurol 4:218 Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R (1995) Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. J Voice 9:453–459 Steep C (2014) Relative fundamental frequency during vocal onset and offset in older speakers with and without Parkinson’s disease. J Acoust Soc Am 133:1637–1643 Tanaka Y, Tsuboi T, Watanabe H, Kajita Y, Fujimoto Y, Ohdake R et al (2015) Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Neurol 262:1173–1181 Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653 Tommasi G, Krack P, Fraix V, Le Bas JF, Chabardes S, Benabid AL et al (2008) Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 79:813–819 Tripoliti E, Zrinzo L, Martinez-Torres I, Frost E, Pinto S, Foltynie T et al (2011a) Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 76:80–86 Tripoliti E, Strong L, Hickey F, Foltynie T, Zrinzo L, Candelario J et al (2011b) Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson’s disease. Mov Disord 26:2434–2436 Tripoliti E, Limousin P, Foltynie T, Candelario J, Aviles-Olmos I, Hariz MI et al (2014) Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov Disord 29:532–538 Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Yoneyama N, Hara K, et al. (2015) Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-308043 Wertheimer J, Gottuso AY, Nuno M, Walton C, Duboille A, Tuchman M et al (2014) The impact of STN deep brain stimulation on speech in individuals with Parkinson’s disease: the patient’s perspective. Parkinsonism Relat Disord 20:1065–1070